Legend Biotech Corp Income Statement

Income Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 49.13M59.98M75.00M68.83M117.00M285.14M627.24M
Cost of Revenue 65.36M144.21M216.37M
Gross Profit 49.13M59.98M75.00M68.83M51.64M140.93M410.88M
Operating items
Research & Development 60.64M161.94M232.16M313.35M335.65M382.22M413.54M
Selling, General & Administrative -6.75M-23.13M-46.96M-80.63M-0.11M-0.14M
Operating Expenses 60.64M155.19M210.43M266.38M255.02M382.11M413.41M
Operating Income -203.38M-241.18M-2.53M
EBIT -1.53M-127.10M-304.08M-406.30M-203.38M-241.18M-2.53M
Non-operating items
Interest & Investment Income 6.21M4.58M2.93M0.97M-8.18M
Other Non Operating Income -0.07M4.87M9.16M
Net income details
EBT -1.62M-127.32M-308.29M-407.20M-445.72M-520.12M-158.13M
Tax Provisions 1.17M-25.73M-41.91M-3.61M0.62M-1.90M18.90M
Profit After Tax -2.78M-101.59M-266.37M-403.58M-446.35M-518.25M-177.03M
Income from Continuing Operations -2.78M-101.59M-266.37M-403.58M-446.35M-518.22M-177.03M
Consolidated Net Income -2.78M-101.59M-266.37M-403.58M-446.35M-518.22M-177.03M
Income towards Parent Company -2.78M-101.59M-266.37M-403.58M-446.35M-518.25M-177.03M
Net Income towards Common Stockholders -2.78M-101.59M-266.37M-403.58M-446.35M-518.25M-177.03M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 258.70M258.70M290.66M308.70M363.58M366.90M
Shares Outstanding (Diluted Average) 200.00M236.31M281.70M318.08M
EBITDA -1.53M-127.10M-304.08M-406.30M-203.38M-241.18M-2.53M
Tax Rate 20.21%13.60%0.89%0.37%